Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Vaccine composition and preparation method and application thereof

A technology of vaccine composition and antigen, applied in the field of vaccine composition, can solve problems such as the decline in the quality of the preventive effect, stress and safety issues

Active Publication Date: 2015-02-11
PU LIKE BIO ENG
View PDF9 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] When using vaccines to prevent and treat these three diseases, multiple injections of a single vaccine will cause stress and safety issues, and the quality of the prevention effect will decline

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Vaccine composition and preparation method and application thereof
  • Vaccine composition and preparation method and application thereof
  • Vaccine composition and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] The preparation of embodiment 1, SIV, Mhp, APP antigen

[0038] 1. The source of bacteria (virus) strains

[0039] The SIV H1N1ZJS strain was isolated and preserved in our laboratory, the preservation number is CCTCC NO: V201233, and the preservation date is September 11, 2012.

[0040] Mhp HN0613 strain, isolated and preserved in our laboratory, the preservation number is CCTCC NO: M2012230, and the preservation date is June 13, 2012.

[0041] APP1 type LC strain, isolated and preserved in our laboratory, the preservation number is CCTCC NO: M2011458, and the preservation date is December 9, 2011.

[0042] 2. Preparation and inspection of vaccine semi-finished products

[0043] 2.1 Preparation of seeds for production

[0044] 2.1.1 Swine influenza virus

[0045] The SIV H1N1ZJS strain was inoculated into SPF chicken embryos for subculture, and the allantoic fluid was harvested as the virus fluid. The first generation was F1 and then passed to F3. The allantoic flui...

Embodiment 2

[0082] Example 2. Preparation of vaccine composition

[0083] 1 Preparation of preservatives

[0084] 1% (w / v) thimerosal (Sinopharm Chemical Reagent Co., Ltd. 20120106) aqueous solution

[0085] 2 preparation of diluent

[0086] Sterile PBS (0.01M, pH=0.02) buffer solution: dissolve 8g sodium chloride, 0.25g potassium chloride, 3.63g disodium hydrogen phosphate, 0.24g potassium dihydrogen phosphate in 900ml purified water, then dilute to 1L, autoclave at 121°C for 30 minutes for later use.

[0087] 3 preparation of adjuvants

[0088] Gel01 (French SEPPIC company 20120401), autoclaved at 121°C for 30 minutes for use.

[0089] 4 with seedlings

[0090] Take the Mhp, SS2, and SESZ prepared in Example 1 to concentrate inactivated antigens, make mixed antigen solution or directly make antigen solution according to the final antigen content in the joint vaccine and single vaccine, and then mix the antigen solution and Gel01 adjuvant at 90: 10 (v / v) mixed, supplemented to the ...

Embodiment 3

[0120] Example 3. This study is to evaluate the promoting effect of mixed infection of SIV, Mhp and APP on the pathogenesis of APP, so as to prove the synergistic effect of mixed infection of the three.

[0121] 1 Material:

[0122] Animals: 60-70 days old, pigs with negative serum antibodies to SIV, Mhp and APP

[0123] Attacking strains: SIV H1N1ZJS strain, Mhp CVCC354 strain (purchased from China Veterinary Drug Administration), APP type 1 LC strain

[0124] 2 methods:

[0125] Fifty piglets aged 60-70 days were selected and randomly divided into 10 groups with 5 pigs in each group. Different doses of APP1 type LC strains were used to challenge pigs in groups 1 to 3, and the incidence was counted after 14 days of observation; the attacking doses of SIV H1N1ZJS strain and different doses of APP type 1 LC strains were used to attack pigs in groups 4 and 5, and observations were made for 14 days. Incidence situation: Use the CVCC354 strain of the disease dose and the APP ty...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a vaccine composition. The vaccine composition comprises SIV antigens in immune amount, Mhp antigens in immune amount, APP antigens in immune amount and a carrier acceptable on the veterinary medicine. The vaccine composition is simple in immune procedure; and single infecting or mixed infecting of SIV, Mhp and APP can be effectively prevented and treated. When mixed infecting occurs, the immune effect of the vaccine composition is obviously better than the immune effect of respectively-injected single vaccines. The vaccine composition is small in composition side reaction, long in immunity period, short in spent time, less in wasted labor, simple in production process, low in immune cost and high in practicability.

Description

technical field [0001] The present invention relates to a vaccine composition. Background technique [0002] Swine influenza (SI) is an acute, febrile and highly contagious respiratory infectious disease caused by swine influenza virus (SIV), characterized by sudden onset, cough, dyspnea, fever, and failure, followed by rapid recovery or death as a feature. Pigs of all varieties, sexes and ages can be infected with a high incidence rate. When influenza breaks out in swine herds, the incidence rate can reach 100%. The typical clinical symptoms of swine flu are runny nose, cough and dyspnea, accompanied by fever, lethargy and subsequent anorexia and weight loss. SIV seldom causes death in the case of single infection, but mixed infection with PRRSV, PCV2 and Mhp will significantly increase the degree of damage and fatality of the above diseases. In addition, SIV is also the main pathogen of porcine respiratory disease syndrome. The damage caused by co-infection or secondar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K39/295A61P31/04A61P31/00A61P31/16A61P11/00
Inventor 张许科孙进忠田克恭
Owner PU LIKE BIO ENG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com